|
The impetus of Blood Cancer Journal is the deliberate dissemination of pre-clinical and clinical work in the field of hematology with ramifications into translational biology research down to new therapies.
Topics of particular concentration will include, but are not limited to, the following:
•Careful analysis of validation of in-vitro experimentations of new compounds devoted to phase 1 studies
•Murine models
•Therapies such as specific inhibitory molecules, antibodies, immunotherapy manipulations
Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.
|
